Kintara Therapeutics Inc Ownership
$2.10
0.48%
Nasdaq, Sep 18, 04:00 pm EDT.
Closed.
Kintara Therapeutics Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Patel (Vijay)
|
12.263m | 19.26% | +4.264m | Apr 30 2026 |
| 2 |
Nachtrab (Matthew)
|
4.083m | 6.41% | +1.771m | Apr 30 2026 |
| 3 |
Patel (Samir Rashmikant)
|
2.628m | 4.13% | -138.448k | Apr 30 2026 |
| 4 |
Bianco (James A)
|
2.323m | 3.65% | — | Apr 30 2026 |
| 5 |
BlackRock Institutional Trust Company, N.A.
|
2.280m | 3.58% | +849.198k | Mar 31 2026 |
|
1
Patel (Vijay)
|
19.26%
12.263m
|
|
2
Nachtrab (Matthew)
|
6.41%
4.083m
|
|
3
Patel (Samir Rashmikant)
|
4.13%
2.628m
|
|
4
Bianco (James A)
|
3.65%
2.323m
|
|
5
BlackRock Institutional Trust Company, N.A.
|
3.58%
2.280m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 37.02% of Kintara Therapeutics Inc, with Patel (Vijay) the biggest at 19.26%, followed by Nachtrab (Matthew) (6.41%) and Patel (Samir Rashmikant) (4.13%). |
Kintara Therapeutics Inc Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Kintara Therapeutics Inc has risen over the past 12 months from around 5.9% to 12.7% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
